With the IPO pipeline full to the brim (currently sitting at 68), the first full week after the Memorial day weekend is loaded. Currently eight deals are planned to come this week with the potential for Monday biotech launches to come.
Technology will be in the spotlight as five of the eight deals come from this sector. Luxury e-commerce company, 1stdibs.com, Inc. (DIBS), is seeking a market cap of $659m-$769m based on the $18-$21 range. Will the annual year-over-year revenue growth rate of 58% attract syndicate buyers to the stock?
The week could potentially raise more than $4bn in cash for companies. Subscribe to IPO Boutique to know which deals are generating the most demand and which offering you should indicate for!
Check out the IPO Boutique Pipeline Page HERE!
Tuesday (6/8) Debut
- Zhangmen Education Inc. (ZME) — They are a leading online education company in China focused on providing personalized online courses to K-12 students according to the Frost & Sullivan Report.
Wednesday (6/9) Debut
- Marqeta Inc. (MQ) — They created modern card issuing, and we believe modern card issuing is at the heart of today’s digital economy.
Thursday (6/10) Debut
- 1stdibs.com, Inc (DIBS) — They are one of the world’s leading online marketplaces for connecting design lovers with many of the best sellers and makers of vintage, antique, and contemporary furniture, home décor, jewelry, watches, art, and fashion.
- LifeStance Health Group (LFST) — They are dedicated to improving the lives of our patients by reimagining mental health through a disruptive, tech-enabled in-person and virtual care delivery model built to expand access and affordability, improve outcomes and lower overall health care costs.
- Monday.Com, Inc (MNDY) — monday.com democratizes the power of software so organizations can easily build software applications and work management tools that fit their needs.
- Zeta Global Holdings Corp (ZETA) — They are a leading omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software.
Friday (6/11) Debut
- Janux Therapeutics (JANX) — They are an innovative biopharmaceutical company developing next-generation therapeutics based on our proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
- Zenvia Inc. (ZENV) — They empower companies to transform their existing customer communications from non-scalable, physical and impersonal interactions into highly scalable, digital first and hyper contextualized customer journey experiences. The company is seeking a market cap of $570m-$644m based on the $15.50-$17.50 range.
- Vera Therapeutics, Inc (VERA)) – They are a clinical stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company is seeking a market cap of $287m-$328m based on the $14-$16 range.
Indicating for IPOs or Secondary offerings? Place IPO Boutique on your team.
https://www.ipoboutique.com/blog/register/
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish